Covid-19 Pill Developer to Spend SPAC IPO Funds on Clinical Trial, Hiring

Biopharmaceutical firm Pardes Biosciences plans to spend a large chunk of the funds it raised through a public offering late last month on a pill it is developing to treat Covid-19, including on …
( read original story …)